成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

化合物 Topoisomerase I inhibitor 5,Topoisomerase I inhibitor 5
  • 化合物 Topoisomerase I inhibitor 5,Topoisomerase I inhibitor 5

化合物 Topoisomerase I inhibitor 5|T61501|TargetMol

價(jià)格 19420 24625 14900
包裝 50mg 100mg 25mg
最小起訂量 1mg
發(fā)貨地 上海
更新日期 2024-12-02
QQ交談 微信洽談

產(chǎn)品詳情

中文名稱:化合物 Topoisomerase I inhibitor 5英文名稱:Topoisomerase I inhibitor 5
CAS:2513461-95-3品牌: TargetMol
產(chǎn)地: 美國(guó)保存條件: Shipping with blue ice.
產(chǎn)品類別: 抑制劑
貨號(hào): T61501
2024-12-02 化合物 Topoisomerase I inhibitor 5 Topoisomerase I inhibitor 5 50mg/19420RMB;100mg/24625RMB;25mg/14900RMB 19420 TargetMol 美國(guó) Shipping with blue ice. 抑制劑

Product Introduction

Bioactivity

名稱Topoisomerase I inhibitor 5
描述Topoisomerase I inhibitor 5 is an efficient inhibitor of topoisomerase I, with an IC50 value. It effectively disrupts DNA and inhibits the activity of topoisomerase I. Moreover, it can induce apoptosis in MCF-7 cells and arrest the cell cycle at the G1 phase. Topoisomerase I inhibitor 5 also exhibits potency in reversing P-gp-mediated resistance to Adriamycin [1].
體外活性Topoisomerase I inhibitor 5 (compound 14) (0-50 μM; 48 hours) exhibits antiproliferation activity against cancer cell lines and lower cytotoxicity in normal cells [1]. Topoisomerase I inhibitor 5 (2-8 μM; 24 hours) induces MCF-7 cell cycle arrest at the G1 phase [1]. Topoisomerase I inhibitor 5 (2-8 μM; 48 hours) increases the apoptotic rate of MCF-7/ADR and MCF-7 cells [1]. Topoisomerase I inhibitor 5 (1.5-6 μM; 24 hours) increases the expression degree of cleaved-caspase-3 and cleaved-PARP in MCF-7; down-regulates the level of anti-apoptotic protein, up-regulates the levels of pro-apoptotic proteins in MCF-7/ADR [1]. Topoisomerase I inhibitor 5 (0.1 μM; 24 hours) induces cell apoptosis by promoting the accumulation of ROS in MCF-7/ADR cell [1]. Topoisomerase I inhibitor 5 (10 μg/ml; 24 hours) increases the accumulation of the ADR and Rh123 in MCF-7/ADR cells [1]. Topoisomerase I inhibitor 5 (5, 10 and 20 μM; 24 hours) reduces the expression degree of P-gp by 14.95% and 18.10% in MCF-7/ADR cells at 10 and 20 μM [1]. Cell Proliferation Assay Cell Line: A549, HepG-2, MCF-7, MDA-MB-231, MCF-7/ADR and LO2 cells [1] Concentration: 0-50 μM Incubation Time: 48 hours Result: Exhibited antiproliferation activity against cancer cell lines, with IC 50 s of 2.39 ± 0.23 μM, 4.88 ± 0.29 μM, 1.32 ± 0.14 μM, 7.64 ± 0.35 μM and 2.42 ± 0.14 μM in A549, HepG-2, MCF-7, MDA-MB-231, MCF-7/ADR, respectively; and has lower cytotoxicity in LO2 cells with IC 50 of 36.52 ± 2.36 μM. Cell Cycle Analysis Cell Line: MCF-7 [1] Concentration: 2, 4 and 8 μM Incubation Time: 24 hours Result: Induced MCF-7 cell cycle arrest at the G1 phase. Apoptosis Analysis Cell Line: MCF-7 and MCF-7/ADR cells [1] Concentration: 2, 4 and 8 μM Incubation Time: 48 hours Result: Induced apoptosis in a dose-dependent manner in MCF-7 cells, and increased the apoptotic rate of the cells from 2.8% to 15.2% in MCF-7/ADR. Western Blot Analysis Cell Line: MCF-7 [1] Concentration: 1.5, 3 and 6 μM in MCF-7; 5, 10, and 20 μM in MCF-7/ADR Incubation Time: 24 hours Result: Increased the expression degree of cleaved-caspase-3 and cleaved-PARP in MCF-7; down-regulated the level of anti-apoptotic protein bcl-2, up-regulated the levels of pro-apoptotic proteins bax and bad in MCF-7/ADR.
體內(nèi)活性Topoisomerase I inhibitor 5 (1 mg/kg and 10 mg/kg; IV; every two days, for 21 days) decreases the tumor growth significantly [1]. Animal Model: Bal b/c nude mice (injected with 106 MCF-7 cells in the left flank for 7 days) [1] Dosage: 1 mg/kg and 10 mg/kg Administration: IV; every two days, for 21 days Result: Decreased the tumor growth significantly and the tumor inhibition ratio reached to 32.4% at 1 mg/kg and 7.2% at 10 mg/kg.
存儲(chǔ)條件Shipping with blue ice.
關(guān)鍵字: Topoisomerase I inhibitor 5|TargetMol

公司簡(jiǎn)介

TargetMol Chemicals Inc. 總部位于馬薩諸塞州波士頓,致力于為全球生化領(lǐng)域科學(xué)家的研究提供專業(yè)的產(chǎn)品和服務(wù)。TargetMol?品牌的客戶群分布于40多個(gè)國(guó)家和地區(qū),已發(fā)展成為全球知名的化合物庫(kù)和小分子化合物研究供應(yīng)商。 TargetMol?可提供160多種滿足不同需求的化合物庫(kù),以及多種類型的生化試劑產(chǎn)品,包括12000多種抑制劑、16000多種天然產(chǎn)物和各類多肽、抗體、生命科學(xué)試劑盒等,此外,我們還建設(shè)有CADD(計(jì)算機(jī)輔助藥物設(shè)計(jì))研究中心、藥理實(shí)驗(yàn)室、藥化合成平臺(tái)三大技術(shù)中心,全方位滿足客戶的定制需求。 憑借我們優(yōu)質(zhì)的產(chǎn)品和服務(wù)、快速高效的全球供應(yīng)鏈和專業(yè)的技術(shù)支持,我們將有效幫助您縮短研發(fā)周期,取得更成功的結(jié)果。
成立日期 2013-04-18 (12年) 注冊(cè)資本 589.8595萬人民幣
員工人數(shù) 100-500人 年?duì)I業(yè)額 ¥ 1億以上
主營(yíng)行業(yè) 中間體,天然產(chǎn)物,生物化工,化學(xué)試劑,生物技術(shù)服務(wù) 經(jīng)營(yíng)模式 貿(mào)易,工廠,試劑,定制,服務(wù)
  • TargetMol中國(guó)(陶術(shù)生物)
VIP 1年
  • 公司成立:12年
  • 注冊(cè)資本:589.8595萬人民幣
  • 企業(yè)類型:有限責(zé)任公司(自然人投資或控股)
  • 主營(yíng)產(chǎn)品:抑制劑&激動(dòng)劑,天然產(chǎn)物,重組蛋白,化合物庫(kù),技術(shù)服務(wù)
  • 公司地址:上海市靜安區(qū)江場(chǎng)三路238號(hào)8樓
詢盤

化合物 Topoisomerase I inhibitor 5|T61501|TargetMol相關(guān)廠家報(bào)價(jià)

產(chǎn)品名稱 價(jià)格   公司名稱 報(bào)價(jià)日期
詢價(jià)
碧云天生物技術(shù)有限公司
2025-01-30
詢價(jià)
VIP3年
上海嘉定區(qū)澄瀏公路52號(hào)
2025-02-06
詢價(jià)
VIP2年
陜西締都新材料有限公司
2024-12-18
內(nèi)容聲明:
以上所展示的信息由商家自行提供,內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布商家負(fù)責(zé)。 商家發(fā)布價(jià)格指該商品的參考價(jià)格,并非原價(jià),該價(jià)格可能隨著市場(chǎng)變化,或是由于您購(gòu)買數(shù)量不同或所選規(guī)格不同而發(fā)生變化。最終成交價(jià)格,請(qǐng)咨詢商家,以實(shí)際成交價(jià)格為準(zhǔn)。請(qǐng)意識(shí)到互聯(lián)網(wǎng)交易中的風(fēng)險(xiǎn)是客觀存在的